RE:RE:RE:RE:Investment friend checked into ONCY"Double the number of survivals" ??? this is dishonest...the reason we are stuck in this range per my biotech analyst friend is that the studies have been small....and the results have small incremental improvements treatment rather than any slam dunk cures...Why would a Pharma throw billions at us when there are dozens of small biotechs working on the same solutions...they can just sit back...let us burn our cash proving the concept then swing down and take us out with little risk....I have a smaller position in XCUR but honestly that looks like a better play...better capitalized..they are going after cancer...but also hair loss and autoimmune diseases....Gates...and the principles of Groupon and Uber have provided the seed money...I am out of my league on this stuff so defer to the recommendations of by my analyst friend and some of the more knowledgeable posters here....I have a sizeable position because this seems like a decent lottery ticket...and I want generational wealth...but might be smarter to follow the herd in the bitcoins....